Risks, benefits, indications, and alternatives to the procedure were explained to the patient. Risks include bleeding and infection. All questions were answered. Both written and verbal informed consent was obtained.
A time-out was performed to confirm the correct patient, procedure, and site.
The patient was placed in the supine, slightly oblique position on the fluoroscopic table. A suitable site at the superior femoral head and neck junction was marked using fluoroscopic guidance and overlying skin prepped and draped in usual sterile fashion.
Lidocaine 1% was used for local and deep anesthesia. A 22-gauge 3-1/2 inch spinal needle was advanced under fluoroscopic guidance. Final intracapsular location was confirmed with injection of a small amount of Omnipaque contrast.
Next, Aristospan 1 mL (20 mg) and bupivacaine 0.5% 3 mL were injected without complication.
The needle was removed and a sterile bandage applied. The patient tolerated the procedure well.
Therapeutic hip injection under fluoroscopic guidance.